Analyst consensus rating
Fresenius Medical Care Analyst Rating: Hold
Direct answer
Fresenius Medical Care's consensus rating is Hold.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $21.99.
Forecast evidence checked November 14, 2026.
Get free Fresenius Medical Care email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $22.03
- Average price target
- $21.99
- High price target
- $34.61
- Low price target
- $15.53
- Low target gap
- -29.5%
- Target upside
- -0.2%
- High target gap
- +57.1%
- Target range width
- 86.6%
- Consensus rating
- Hold
- Analysts
- 7
- Evidence date
- November 14, 2026
- Valid through
- November 21, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Fresenius Medical Care?
Fresenius Medical Care has a verified Hold consensus. The same dataset has an average price target of $21.99.
How far are Fresenius Medical Care's low and high targets from the recorded price?
The low target implies -29.5%, while the high target implies +57.1%.
How many analysts are included in Fresenius Medical Care's consensus?
The verified consensus includes 7 analysts.
How is Fresenius Medical Care's target upside or downside calculated?
The average target of $21.99 is divided by the recorded price of $22.03, then one is subtracted to produce -0.2%. This does not guarantee a future return.
When was Fresenius Medical Care's analyst forecast verified?
The data was verified on 2026-11-14. The dataset is valid through 2026-11-21.